Article
The new technology has the potential to be safer with the delivery of micropulses of BSS, which results in littleor no increase in temperature or vibration inside the eye.
Ocular pain in Tibetan Plateau residents: Key findings on dry eye disease during COVID-19
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
Understanding cerebral/cortical visual impairment: New insights and advances in diagnosis